Anemia, Abnormal Body Mass Index, and Sarcopenia Increase Complication Risk in Patients Undergoing Surgical Treatment for Metastatic Bone Disease
The complication risk for patients with metastatic disease is multifactorial, with anemia, abnormal BMI, and sarcopenia as measured by psoas cross-sectional area increasing risk for nononcologic complications. In the future, large-scale studies can help quantify the impact of each factor to allow for preoperative optimization to reduce complications.
Authors
- Kathleen S. Beebe (ORCID: https://orcid.org/0000-0002-5216-0618)
- Joseph A. Ippolito (ORCID: https://orcid.org/0000-0002-9211-5766)
- Joseph Benevenia
- Yazan Kadkoy (ORCID: https://orcid.org/0000-0002-4705-7026)
- Jennifer E. Thomson (ORCID: https://orcid.org/0000-0002-8829-5768)
- Rosamaria Dias (ORCID: https://orcid.org/0009-0000-5806-7986)
- Ashley Castan (ORCID: https://orcid.org/0009-0006-0503-4957)
- Katie Gotoff
Institutions
- Rutgers, The State University of New Jersey (US)
- Rutgers New Jersey Medical School (US)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1002/jso.28135
- Citations
- 2
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 4.01